The novel immunomodulator, Linomide, stimulates interleukin-2-induced human natural killer (NK) cell and PHA-stimulated T cell proliferation from normal donors

Donor-derived cell-mediated immunotherapy has been shown to be an effective tool for reinduction of remission in chronic myeloid leukemia (CML) patients who have relapsed post-bone marrow transplantation (BMT). Linomide, quinoline-3-carboxamine (LS 2616), is a new immunomodulator shown to increase t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia research 1996, Vol.20 (1), p.57-63
Hauptverfasser:	Condiotti, Reba, Slavin, Shimon, Barak, Vivian, Nagler, Arnon
Format:	Artikel
Sprache:	eng
Schlagworte:	Adjuvants, Immunologic - pharmacology Biological and medical sciences Cytotoxicity, Immunologic - drug effects Humans Hydroxyquinolines - pharmacology Immunomodulator Immunomodulators immunotherapy Interleukin-2 - pharmacology Killer Cells, Natural - drug effects Killer Cells, Natural - immunology Linomide Lymphocyte Activation - drug effects Medical sciences NK cells Pharmacology. Drug treatments Phytohemagglutinins - pharmacology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!